Cipla launches new anti-HIV drug


NEW DELHI: Pharma major Cipla on Thursday launched its fixed dose single pill anti-HIV drug Viraday priced at Rs 5,200 a month.

Viraday is a combination of three anti-HIV drugs -- Efavirenz 600 mg, Tenofovir 300 mg and Emtricitabine 200 mg, a company official said here.

"We are offering the drug at Rs 5,200 a month which is a fraction of the international price of approximately USD 1,100 (about Rs 52,800 a month)," he said.

While the company is introducing this drug in India for the first time, it is also looking at export opportunity, especially in Africa, the official said.

About this Entry

This page contains a single entry by ID Admin published on October 13, 2006 12:54 PM.

Criticism over Taiwan court ruling for removal of HIV refuge was the previous entry in this blog.

HMS Starts HIV Database is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.


Powered by Movable Type 4.24-en